Introduction to the Launchpad program

Introduction

The diagnosis section of The Launchpad will help attendees identify migraine from other primary headache disorders, review red flags to help rule out secondary causes of headache, highlight important aspects of the headache history and physical exam, and provide tips to help with migraine diagnosis.

The diagnosis section of The Launchpad will help attendees identify migraine from other primary headache disorders, review red flags to help rule out secondary causes of headache, highlight important aspects of the headache history and physical exam, and provide tips to help with migraine diagnosis.

Acute migraine management is one of the most important components in managing patients with migraine disorders. This presentation will discuss medications, devices, and behavioral techniques that can be implemented in a stratified approach to meet the needs of a diverse patient population. Indications, contraindications, and clinical pearls will be addressed so clinicians feel confident in building an individualized acute migraine toolkit for their patients.

Acute migraine management is one of the most important components in managing patients with migraine disorders. This presentation will discuss medications, devices, and behavioral techniques that can be implemented in a stratified approach to meet the needs of a diverse patient population. Indications, contraindications, and clinical pearls will be addressed so clinicians feel confident in building an individualized acute migraine toolkit for their patients.

This lecture is designed to enhance knowledge around preventative treatment of migraine. After understanding the goals of therapy, the lecture content will enhance assessment and decision-making strategies as to when preventative treatment is required or should be considered, as well as how to choose appropriate therapies. The lecture will review effective therapeutic options and which therapies to choose based on scientific evidence and clinical presentation. In addition to pharmacological options, lifestyle modification strategies and nutraceutical options will be discussed, along with available non-pharmacologic devices. Response to therapy and determining effectiveness of preventative treatment will be reviewed. Learning will be summarized through discussion of case presentations

We will discuss evidence-based behavioral and non-pharmacological treatments for headache disorders. The behavioral therapies include cognitive behavioral therapy, biofeedback, and relaxation training. The non-pharmacological treatments include acupuncture, yoga, and taichi. We will focus on the patient experience when undergoing these treatments and what providers can do to help guide their patients.

We will discuss evidence-based behavioral and non-pharmacological treatments for headache disorders. The behavioral therapies include cognitive behavioral therapy, biofeedback, and relaxation training. The non-pharmacological treatments include acupuncture, yoga, and taichi. We will focus on the patient experience when undergoing these treatments and what providers can do to help guide their patients.

As part of the Launchpad to Headache Essentials program, this presentation will provide an introduction to the care of children, adolescents, and young adults who are living with a headache disorder. Topics will include: epidemiology and impact; diagnosis; education and lifestyle goals; acute treatment; and preventive treatment. There will be a focus on current evidence and practice as well as taking a developmental approach to management and collaborative care with youth and their families. A pediatric neurologist and pediatric psychologist will co-present on this topic.

As part of the Launchpad to Headache Essentials program, this presentation will provide an introduction to the care of children, adolescents, and young adults who are living with a headache disorder. Topics will include: epidemiology and impact; diagnosis; education and lifestyle goals; acute treatment; and preventive treatment. There will be a focus on current evidence and practice as well as taking a developmental approach to management and collaborative care with youth and their families. A pediatric neurologist and pediatric psychologist will co-present on this topic.

The trigeminal autonomic cephalalgias are a collection of several headache disorders (hemicrania continua, cluster headache, paroxysmal hemicrania, SUNCT, and SUNA) with similar features that differ in timing and frequency. Cluster headache is uncommon (1 in 1000) while the rest of the headaches are rare (1 in 10,000 or less). The diagnoses are based on clinical criteria that include unilateral pain with ipsilateral autonomic features (such as eye watering and nasal congestion). The cause of these headaches is unclear but is thought to involve the trigeminal pain system, the facial autonomic pathway, and the hypothalamus. The headaches also differ in their treatment. For cluster headache, the first-line treatments are oxygen, sumatriptan injections, prednisone, and verapamil. For “hemicrania” headaches (hemicrania continua and paroxysmal hemicrania), indomethacin is so effective that it is included in the official criteria of these headaches. For SUNCT and SUNA, the headaches are so brief that acute treatments take too long and the first-line preventive is lamotrigine.

The trigeminal autonomic cephalalgias are a collection of several headache disorders (hemicrania continua, cluster headache, paroxysmal hemicrania, SUNCT, and SUNA) with similar features that differ in timing and frequency. Cluster headache is uncommon (1 in 1000) while the rest of the headaches are rare (1 in 10,000 or less). The diagnoses are based on clinical criteria that include unilateral pain with ipsilateral autonomic features (such as eye watering and nasal congestion). The cause of these headaches is unclear but is thought to involve the trigeminal pain system, the facial autonomic pathway, and the hypothalamus. The headaches also differ in their treatment. For cluster headache, the first-line treatments are oxygen, sumatriptan injections, prednisone, and verapamil. For “hemicrania” headaches (hemicrania continua and paroxysmal hemicrania), indomethacin is so effective that is included in the official criteria of these headaches. For SUNCT and SUNA, the headaches are so brief that acute treatments take too long and the first-line preventive is lamotrigine.

This presentation will take you through the woman's migraine journey. We will demonstrate the impact of different estrogen states on migraine​ throughout the lifespan. Discuss techniques and best practices to initiate conversations with patients about plans for conception and childbearing . Finally we will focus on the importance of educating patients patients on options for the treatment of migraine during and in anticipation of pregnancy, and while breastfeeding.

In this session we will review the influence of hormones on migraine, including during puberty, menstruation, pregnancy, and menopause. We will also address topics specific to migraine and pregnancy, including initiating the conversation of pregnancy planning with patients who have migraine as well as management of migraine during pregnancy and breastfeeding.

The presentation covers secondary headaches that headache medicine clinicians encounter which require urgent evaluation and treatment in order to avoid dire consequences. We discuss these diseases using case based approach with a focus on diagnosis.

The presentation covers secondary headaches that headache medicine clinicians encounter which require urgent evaluation and treatment in order to avoid dire consequences. We discuss these diseases using case based approach with a focus on diagnosis.